Title
Category
Credits
Event date
Cost
Opioids and Naloxone: Overdose Recognition, Response, and Prevention
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 BDEA
05/20/2026
$0.00
The opioid crisis continues to impact individuals, families, and communities. Timely naloxone administration has proven to be one of the most effective tools in preventing fatal opioid overdoses, yet barriers to access, education, and stigma persist. This webinar will provide an overview of the current opioid landscape, including overdose trends and risk factors. Participants will learn how to recognize an opioid overdose and understand how naloxone works.
Medical Cannabis in Clinical Practice: Evidence, Applications, and Cautions
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 ACPE Technician
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 BDEA
06/03/2026
$0.00
Medical cannabis has gained increasing acceptance as a potential therapeutic option for a range of medical and behavioral health conditions. This session provides an evidence-based overview of medical cannabis, including its pharmacology, approved and off-label clinical indications, and known benefits and limitations. Participants will review current evidence regarding efficacy, safety concerns, and potential adverse effects, as well as variability in products, dosing challenges, and drug–drug interactions.
Strengthening Community-Based Prevention: Strategies for Addressing Substance Misuse in Alabama
  • COACH
  • 3.60 ABN
  • 3.00 ABSWE
  • 3.00 ACPE Pharmacy
  • 3.00 ACPE Technician
  • 3.00 AMA PRA Category 1 Credit™
  • 3.00 BDEA
06/30/2026
$0.00
This three-hour continuing education program equips Alabama’s mental health, healthcare, and community-based professionals with practical strategies to strengthen substance misuse prevention efforts. Through a combination of presentations and interactive breakout sessions, participants will explore current drug trends, medical cannabis considerations, and naloxone use alongside critical prevention competencies such as reducing stigma, understanding community norms, and applying accessible tools for data collection and evaluation.
Buprenorphine for Opioid Use Disorder: Clinical Effectiveness, Safety, and Access
  • COACH
  • 1.00 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 ACPE Technician
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 BDEA
08/12/2026
$0.00
Buprenorphine is a cornerstone medication for the treatment of opioid use disorder (OUD) and plays a critical role in reducing overdose risk and improving treatment retention. This session provides an overview of buprenorphine’s pharmacology, effectiveness, and role within evidence-based OUD treatment. Participants will review initiation strategies, maintenance therapy, and considerations for special populations. The session will also explore safety issues, diversion concerns, stigma, regulatory changes, and interdisciplinary collaboration to improve patient access and outcomes.

Pages